Orthox Secures Funds Approaching £3 million from Wellcome Trust and Technology Strategy Board to Support Clinical Development Programme
Oxford, UK – 29th October 2013 – Orthox Limited, the medical implant company developing strong, resilient, tissue regenerative silk implants, today announced awards worth £2.9